That yet again reminded me…do you guys still distinguish between target/outcome/feature cohort? for example, if the cohort of migraine is a feature cohort that will be used for, say, Table 1, wouldn’t we include h/o of migraine since we are tolerant to index event misspecification and care more about sensitivity?
A side note: if you’re still working on that big phenotype paper, it would be nice to include all of the above in it (nice figures, yesss!). And if any help is needed, I’d love to contribute